High concentrations of activin a in the peritoneal fluid of women with epithelial ovarian cancer

被引:12
|
作者
Cobellis, L
Reis, FM
Luisi, S
Danero, S
Pirtoli, L
Scambia, G
Petraglia, F
机构
[1] Univ Siena, Dept Pediat, I-53100 Siena, Italy
[2] Univ Siena, Dept Reprod Med, I-53100 Siena, Italy
[3] Univ Fed Minas Gerais, Dept Obstet & Gynecol, Belo Horizonte, MG, Brazil
[4] Univ Cattolica Sacro Cuore, Dept Gynecol, Rome, Italy
关键词
activin; ovarian cancer; ovarian cyst; peritoneal fluid;
D O I
10.1016/j.jsgi.2003.10.008
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
OBJECTIVE: The aim of the present study was to evaluate the concentrations of activin A in the peritoneal fluid of women with epithelial (serous) ovarian cancer. METHODS: A group of 160 women was studied and divided in four subgroups as follows: 1) serous ovarian carcinoma (n = 32); 2) serous ovarian cystadenoma (n = 20); 3) endometriosis (n = 53); and 4) healthy controls (n = 55), including both fertile (n = 32) and postmenopausal women (n = 23). Specimens of peritoneal fluid were collected during surgical interventions, and activin A was quantified using a specific two-site enzyme immunoassay. RESULTS: Peritoneal fluid activin A concentrations in women with ovarian carcinoma were about five-fold higher than those found in the control group (median [interquartile range] = 7.60 [2.85-10.15] and 1.50 [1.00-2.50] ng/mL, respectively, P <. 001). In contrast, the women with benign serous cystadenoma had peritoneal fluid activin A concentrations (1. 50 [1.0-2. 70] ng/mL) similar to those of the control group. High peritoneal fluid activin A levels (> 2 multiples of the mean) distinguished carcinoma from cystadenoma with a sensitivity of 72% and a specificity of 80%. The follow-up of nine patients with stage IIIc ovarian cancer showed no apparent relationship between the peritoneal fluid activin A levels and overall survival. No significant difference in peritoneal fluid activin A concentrations between patients with endometriosis and control women was observed. CONCLUSION: Most women with serous ovarian carcinoma had high concentrations of activin A in the peritoneal fluid, supporting a possible role of this growth factor in ovarian cancer. Copyright (C) 2004 by the Society for Gynecologic Investigation.
引用
收藏
页码:203 / 206
页数:4
相关论文
共 50 条
  • [41] Molecular analysis of peritoneal fluid in ovarian cancer patients
    Parrella, P
    Zangen, R
    Sidransky, D
    Nicol, T
    [J]. MODERN PATHOLOGY, 2003, 16 (07) : 636 - 640
  • [42] Molecular analysis of inhibin A and activin A subunit gene loci in epithelial ovarian cancer
    DePasquale, S
    Lambert-Messerlian, G
    Quddus, MR
    Campbell, I
    Steinhoff, M
    Gajewski, W
    Granai, C
    Tantravahi, U
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2002, 12 (05) : 443 - 447
  • [43] Secretion of activin A in recurrent epithelial ovarian carcinoma
    Lambert-Messerlian, GM
    DePasquale, SE
    Maybruck, WM
    Steinhoff, MM
    Gajewski, WH
    [J]. GYNECOLOGIC ONCOLOGY, 1999, 74 (01) : 93 - 97
  • [44] Diagnostic value of serum activin A and follistatin levels in women with peritoneal, ovarian and deep infiltrating endometriosis
    Reis, Fernando M.
    Luisi, Stefano
    Abrao, Mauricio S.
    Rocha, Ana Luiza L.
    Vigano, Paola
    Rezende, Carolina P.
    Florio, Pasquale
    Petraglia, Felice
    [J]. HUMAN REPRODUCTION, 2012, 27 (05) : 1445 - 1450
  • [45] HOW TO DEAL WITH MICROSCOPIC PERITONEAL METASTASES OF EPITHELIAL OVARIAN CANCER?
    Azais, H.
    Estevez, J. P.
    Kerbage, Y.
    Mordon, S.
    Collinet, P.
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2017, 27 : 1415 - 1415
  • [46] The Impact of Peritoneal Metastases in Epithelial Ovarian Cancer With Positive Nodes
    Pereira, Augusto
    Magrina, Javier F.
    Magtibay, Paul M.
    Perez-Medina, Tirso
    Fernandez, Ana
    Peregrin, Irene
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2011, 21 (08) : 1375 - 1379
  • [47] Chemotherapy for epithelial ovarian, fallopian tube and primary peritoneal cancer
    Webber, Kate
    Friedlander, Michael
    [J]. BEST PRACTICE & RESEARCH CLINICAL OBSTETRICS & GYNAECOLOGY, 2017, 41 : 126 - 138
  • [48] Peritoneal Immune System in Patients with Advance Epithelial Ovarian Cancer
    Wertel, Iwona
    Nowicka, Aldona
    Rogala, Ewelina
    Kotarski, Jan
    [J]. INTERNATIONAL REVIEWS OF IMMUNOLOGY, 2011, 30 (2-3) : 87 - 101
  • [49] Multimodality Therapy for Peritoneal Metastases from Epithelial Ovarian Cancer
    Magge, D.
    Pingpank, J. F.
    Holtzman, M.
    Ahrendt, S.
    Zeh, H., III
    Bartlett, D.
    Choudry, M. A.
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2016, 23 : S179 - S179
  • [50] Inhibin/activin and ovarian cancer
    Robertson, DM
    Burger, HG
    Fuller, PJ
    [J]. ENDOCRINE-RELATED CANCER, 2004, 11 (01) : 35 - 49